HomeSLNO • NASDAQ
add
Soleno Therapeutics Inc
Previous close
$75.07
Day range
$73.81 - $75.57
Year range
$36.93 - $80.91
Market cap
3.78B USD
Avg Volume
1.14M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 42.78M | 85.39% |
Net income | -43.77M | -104.57% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -42.27M | -87.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 289.95M | 93.78% |
Total assets | 318.09M | 88.40% |
Total liabilities | 85.83M | 237.24% |
Total equity | 232.26M | — |
Shares outstanding | 50.39M | — |
Price to book | 15.67 | — |
Return on assets | -32.95% | — |
Return on capital | -36.69% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -43.77M | -104.57% |
Cash from operations | -32.75M | -161.43% |
Cash from investing | 22.94M | 119.90% |
Cash from financing | 3.22M | 243.07% |
Net change in cash | -6.60M | 94.80% |
Free cash flow | -32.00M | -482.42% |
About
Founded
1999
Headquarters
Website
Employees
115
